AACR20: a nanomedicine news round up

Written by Lucy Chard, Editor

AACR20: nanomedicine in cancer news

The American Association of Cancer Research Virtual Annual Meeting II (AACR20) took place on the 22–24 June 2020. Many new fields in oncological research were showcased, with nanomedicine and nanotechnology featuring in some of the most up and coming topics. A few of my favorite presentations from these important areas of oncology are summarized below.     Immunotherapy in cancer Natural killer cell nanoengagers for improved targeted chemoimmunotherapy Researchers from the University of North Carolina at Chapel Hill (NC, USA) have recently been focusing on the activation of natural killer (NK) cells in cancer immunotherapy. To do this, they propose to simultaneously co-active more than one NK cell...

To view this content, please register now for access

It's completely free